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Mean ± SD. NS = non significant, "'p < 0.001 (paired t-test)
Percutaneous TransRadial Coronary
Revascularization in Elderly Patients
Percutaneous Inoue Endovascular Graft for
Treatment of Canine Aortic Dissection.
Assessment by Intravascular Ultrasound Imaging
(IVUS)
A Novel Method of Sealing of Arterial Puncture
Sites with a Biosealant
James Ferguson, Michael P. Macris, Fred Clubb, Michael J. Cloy, Victor Nikolaychik,
Joseph B. Horn, John E. Baker, Nicholas Kipshidze. Texas Heart Institute, Houston, TX
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Inoue Endovascular Graft (lEG) consisted of cylinder made from thin Dacron
sheet suspended by a framework of extra-flexible wire, We previously re-
ported that lEG was able to be successfUlly placed within the canine true
aneurysm. The purpose of this study is to examine whether lEG can be used
as a device for treatment of dissecting aneurysm. Aortic dissections (De-
Bakey type III) were created non-surgically in 10 dogs. The graft was de-
ployed through 15-F long sheath into the aneurysm to close the entry. The
graft size was chosen according to the diameter of the intact descending
aorta (distal to entry site) by aortography in the same way as true aneurysm
in 5 dogs (group I). In another 5 dogs (group II), the graft size was selected
according to the true lumen diameter by IVUS. The entry was completely
closed after immediate implantation in all dogs used in this study, All 5 dogs
in group I died as long as 11 days (mean, 7 days) after graft deployment. At
autopsy, 3 of 5 dogs showed ruptured aneurysmal wall caused byextravasa-
tion of graft. Remaining 2 dogs, in which entry was not completely covered
by graft, showed complete obstruction of aortic lumen induced by compres-
sion of false lumen, However, all grafts in group II were tolerated very well
and followed-up at 5 months after graft deployment. At that time, there was
6 hematoma, and 2 surgical repairs, one of which for AVfistula 22 days after
procedure. No bleeding requiring blood transfusion occurred.
Conclusion: This new PTRCA is a safe and effective way to perform coro-
nary revascularization with high initial success and low complication rate.
Achieving local hemostasis following coronary interventions especially in pa-
tients with massive anticoagulant therapy still remains a problem in clinical
cardiology. The objective of this study was to investigate the safety and effi-
cacyof a new biosealant (modified fibrin glue) and hemostatic device (Global
Therapeutics, Inc. I to reduce arterial compression time required to achieve
hemostasis at the arterial puncture site. 25 New Zealand rabbits (3-5 kg)
and 10 mongrel dogs (25-40 kg) were used in this study. 5F and 8F intro-
ducers were placed in the femoral arteries in rabbits and dogs respectively.
After complete heparinization the hemostatic device was introduced into
the puncture site through a guide wire and biosealant was applied to the
outside of the vessel. Immediately after removing hemostatic device a light
pressure was applied at the puncture site. Hemostasis was achieved in all
animals. Mean time for hemostasis was 1,2 ± 0.8 min and 5,6 ± 4.1 min
in rabbits and dogs respectively. Histopathology performed 1 month later of
the puncture site in dogs revealed complete reabsorbtion of biosealant with
re-endothelialization and no evidence of inflammation or hind limb thrombo-
sis. We conclude that the hemostatic device with biosealant is a safe and
effective method of hemostasis of arterial puncture sites,
Vascular access complication rate after PTCA is increased in elderly patients
(pts). The goal of this study is to determine whether the use of the new trans
radial approach (TRA) would decrease the rate of vascular complications.
Between February and August 1994, 135 consecutive pts ~70 years old un-
derwent a coronary angioplasty via TRA using a 6F guiding catheter. There
were 96 males, 39 females, with a mean age of 74.9 ± 3.8 years (70-87),
61 % had unstable angina, 17% had a recent myocardial infarction, 73% had
multivessel disease. Conventional balloon angioplasty was performed in 94
pts (70%), Palmaz-Schatz stent implantation in 29 pts (21 %) and rotational
ablation using the rotablator(l.25 or 1.5 mm burr diameter) in 12 pts (9%). In
hospital major cardiac events occurred in 3 pts (2%): one acute closure after
balloon angioplasty successfully recanalized, one non a-wave MI after rotab-
lator procedure and one death three days after coronary stent implantation,
Vascular access complications (2%) included 2 hematoma and one surgical
repair for A V fistula. No bleeding requiring blood transfusion occurred.
Conclusion: This new TRA for coronary revascularization in elderly can be
considered a safe and effective procedure, with a low rate of major cardiac
and arterial puncture site complications.
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1332 ± 342
51 ± 9
1548 ± 309
62 ± 8
Baseline-D-3
1247±218 NS
50 ± 8 NS
1522 ± 256 NS
60 ± 9 NS
1277 ± 281
54 ± 10
1350 ± 374
70 ± 12
Safety Evaluation of a New Infusion-Perfusion
Catheter: Vectocardiographic, Left Ventricular
and Coronary Hemodynamic During Local Drug
Delivery
Results: baseline occlusion hand pump APC
100 psi 200 psi 300 psi 400 psi
HR 116.8 1240 118.9 120.5 117.6 1192 129.2
Ibpmj ±11.4 ±14.7 ±163 ±163 ±31 ±157 ±16.9
AP 93.6 820 79.3 808 742 91.8 76.7
ImmHgl ±93 ±14.4 ±7.4 ±128 ±11.5 ±140 ±22.5
dp/dt 1662 1209 1544 1659 1715 1728 1416
[mmHg/s] ±356 ±435 ±316 ±369 ±567 ±409 ±400
EMF 48.9 0 30.7 456# 493# 64.1# 17.3
/ml/minJ ±28.1 ±378 ±436 ±460 ±541 ±9.1
WT 16.4 -2.7 3.2 57 102# 109# 2.4
I%J ±45 ±46 ±6.8 ±5.2 ±25 ±2.4 ±5.3
CPP 877 35.4 49.8 56.1 79.5# 101.7# 475
ImmHgJ ±14.1 ±33.6 ±31.8 ±261 ±445 ±61.3 ±480
# P < 0.05 vs. occlusion by ANOVA
Clo'se correlations were calculated between applied driVing pressures to
the hand pump and measured changes in dp/dt (r = 0.889). EMF (r = 0.948).
WT (r = 0.972) and CPP (r = 0.801).
Conclusion: The hand pump provides. depending on the applied driving
pressure. better distal coronary perfusion. hemodynamics and maintenance
of wall motion during PTCA compared to autoperfusion catheters.
+dP/dt (mmHg/sec) 1313 ± 195 NS
Vmax (sec1) 52 ± 8 NS
-dP/dt (mmHg/sec) 1634 ± 309
Tau1 (msee) 55 ± 10
Baseline-PTCA
Percutaneous Trans Radial Coronary
Revascularization
Henrique Carvalho, Christian Jordan, Jean Fajadet. Bernard Cassagneau.
Gabriel Robert, Jean-Pierre Laurent, Yves Siboni, Jean Marco. Clinique Pasteur.
Toulouse, France
Percutaneous Trans Radial Coronary Angioplasty (PTRCA) was attempted in
515 consecutive patients (pts): 428 males, 87 females, mean age of 62.6 ±
10.7 years (31-87). 57% of pts had unstable angina, mean LVEF was 61.2
± 10.5% (25%-83%). 68% had multivessel disease. Failure to puncture the
radial artery occurred in 8 pts (1.5%) and to catheterize selectively the coro-
nary artery ostium in 7 pts (1.4%). These 15 pts underwent successful trans-
femoral PTCA and 500 pts effectively underwent PTRCA using a 6F catheter:
362 pts had conventional balloon angioplasty, 119 pts had coronary stenting
and 19 had rotational ablation, No acute major complications occurred during
the procedure. In hospital major cardiac events included one non a-wave MI
after rotablator procedure, one non a-wave MI (side branch occlusion) after
non elective stenting, and one death three days after non elective coronary
stenting, Bleeding orvascular access complications occurred in 8 pts(l ,6%):
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During intracoronary D-3 inflation basal and hyperaemic flow were 44 ±
31 ml/min and 78 ± 59 mllmin.
In conclusion this new infusion catheter allows a nearly normal basal coro-
nary flow with even preserved hyperaemic response during inflation and is
subjectively and hemodynamically well tolerated during prolonged inflation
permitting sustained local intracoronary drug delivery.
Edoardo Camenzind, Carlo di Mario, Jurgen Ligthart, Peter de Jaegere, Pim de
Feyter. Patrick W. Serruys. TlJoraxeentre. Erasmus University, Rotterdam, Netherlands
Aim of the study was to assess adequacy of myocardial perfusion during
deployment of a new intracoronary drug delivery device (D-3. Dispatch '"
Scimed). In 22 patients (13 men, 57 ± 10 years) following conventional an-
gioplasty D-3 was inflated at the site of angioplasty. During inflation blood
velocity was measured distal to the device at baseline and after drug induced
hyperaemia. An angiography was performed to quantify the coronary cross-
sectional area at the site of Doppler sampling volume to calculate blood-flow.
Hemodynamic (high fidelity tip manometer-pigtail in the left ventriclel and
vectorcardiography was monitored continuously. During D-3 inflation (mean
inflation time 29 ± 8 min) 5 patients had mild chest pain. No significant vec-
torcardiographic changes were observed during prolonged inflation, Isovol-
umetric indices of contraction (+dP/dt, V max) and relaxation (-dP/dt, Tau1)
at baseline before PTCA and D-3, at the end of PTCA and D-3 inflation, re-
spectively, were as follows:
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Treatment of Restenosis: Animal Models
Eleftherios B. Sideris, Jung Han Yoon, Chuan-Rong Chen, Maurice Leung,
Rajeev Lochan, Anne-Marie Worms, Bernhard Meier, Christian Rey. Athenian
Institute of Pediatric Cardiology. Athens, Greece, for the International Registry of the
"Buttoned Device" Trials
no rupture of aneurysmal wall and no migration, leakage or damage (rupture
of Dacron cylinder or fracture of wire frame) of graft in all dogs. These grafts
remained patent and pressure gradient (PG) was 14 mmHg except one (PG =
60 mmHgl. This was killed and examined by autopsy. The graft was well cov-
ered by thin, translucent neointima and effectively recreated the new aortic
lumen, completely closing the entry.
Conclusion: 1) Inoue Endovascular Graft was proved to be effective in
treatment of aortic dissection without surgery provided that the graft was
chosen according to true lumen diameter. 2) IVUS was feasible and safe to
provide accurate measurement of true lumen diameter for selection of cor·
rect graft size and guide for implantation site to completely close the entry
lumen.
A feasibility study was conducted for the transcatheter occlusion of large
ostium secundum atrial septal defects (ASOs) using the centering buttoned
device (CBO). The CBO is a modification of the buttoned device, in which a
centering counter-occluder (COC) is sutured at the central 40% portion of the
occluder (OCC); when the centering COC is stretched is forming a balloon
shaped structure, pulling the OCC over the center of the ASO; subsequently
the COC is buttoned with the OCC, forming a double 8 disk on the right side
of the atrial septum. Occlusion was performed in 10 patients 6-56 years old
(median 22). All had been rejected for occlusion by the regular buttoned de-
vice, either because of large defect size, or inadequate septal rim. The defect
size varied between 23-31 mm (median 27) and the device size between 45-
60 mm (median 50). All devices were introduced through 11 F long sheaths.
All patients remained stable. Seven had immediate effective occlusions and
three had residual shunts. Follow·up ranged between 2-6 months. Unbut-
toning without embolization was experienced in the second case; despite
the trivial residual shunt, the patient developed severe hemolysis and was
operated 2 weeks after implantation. The other patients are doing well.
Conclusions: The CBO can offer transcatheter repair in large ASDs cor-
rected only by Surgery in the past. The early results are promising; larger
trials are justified.
p
NS
<0.01
r ~ 0.86
r ~ 0.81
Control
2.1 ± 0.7
0.71 ± 0.36
NI ~ 0.35 x INJ - 030,
NI = 0.43 x INJ - 018,
Hirudin
2.1 ± 0.5
0.44 ± 0.19
Chronic Hirudin Infusion Reduces Neointimal
Thickening After Injury in a Porcine Coronary
Model
SanJay S. Srivatsa, William D. Edwards, Robert D. Siman, David R. Holmes Jr,
Robert S. Schwartz. Mayo Foundation, Rocheste" MN 55905
Group
Hirudin:
Control:
INJ
NI(mm)
Thrombus formation at sites of vascular injury provides cytokines, growth
factors, and biodegradable matrix for cellular migration, proliferation, and
matrix synthesis. We hypothesized that potent limitation ofthrombus deposi-
tion following coronary arterial injury would significantly attenuate restenotic
neointimal formation. Following oversized metallic coil implantation, 26 do-
mestic pigs received either recombinant PEG Hirudin, (7 animals, 1 mg!kg
IV bolus, 0.1 mg!kglhr IV for 5 days) with a goal of keeping the ACT at 200
seconds, or placebo (12 animals). Survival until euthanasia was 28 ± 2 days.
Linear regression models were constructed for planimetered mean neointi-
mal (NI) thickness vs. mean vascular injury score (INJ).
The neointima vs. injury regression equations for each group showed sta-
tistically significant differences in intercept, but not slope:
lumenal patency which appears to be associated with chronic geometric re-
modeling despite concurrent intimal proliferation. Treatment of traumatized
coronary arteries with CB may be useful in diminishing restenosis in patients
undergoing PTCA.
Conclusions: rPEG Hirudin administered early and in doses sufficient to
maintain the activated clotting time at 200 seconds decreased the mean
NI by 0.27 mm, a difference that would be angiographically detectable and
clinically significant.
Prolonged Local Infusion of Low Dose
Angiopeptin Reduces Neointima After Balloon
Injury in Swine Coronaries Using the Dispatch'·
Site-Specific Delivery Catheter
Edward C. Santoian, Norman Tarazona, Marc A. Taylor, Richard A. Kovach, Steven
A. Malosky., Charles A. Dennis. Deborah Heart & Lilng Center Brown Mills, NJ;
Deborah Research Institute, Browns Mills, NJ
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Occlusion of Large Atrial Septal Defects with a
Centering Buttoned Device: Early Clinical
Experience
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The predominant role of geometric remodeling in restenosis after percu-
taneous coronary angioplasty (PTCA) has recently been described. In this
study, Cytochalasin B (CB), a compound which reversibly blocks actin poly-
merization and thereby inhibits smooth muscle contraction and geometric
remodeling, was tested for its abilityto inhibit restenosis after balloon trauma
in a swine coronary model. The left circumflex artery was traumatized with a
torquable embolectomy catheter and treated with either saline, 0.1 "g/ml or
1.5 flg/ml CB applied directly to the arterial wall with a Cordis Microporous
Infusion Catheter (MIC). Pigs were sacrificed 3 weeks post-surgery and the
left coronary artery was processed for histopathology. Histologically, trauma-
tized and treated coronary arteries in all groups were characterized by tears
in the internal elastic lamina which occasionally extended into the tunica me-
dia, reorientation of the inner myofibers of the tunica media perpendicular to
the lumen, occasional dissecting aneurysms, and intimal hyperplasia. Mor-
phometric evaluation of vascular lumenal area demonstrated a significant
difference between treatment groups and the saline control. Saline control
pigs had a mean lumenal area of 55.8% (44.2% stenosis) compared to the
mean of the proximal and distal vessel lumen areas. Pigs treated with 0.1
flg/ml CB had lumenal areas of 92.1 % (7.9% stenosis, p < 0.01). and pigs
treated with 1.5 flg/ml CB had lumenal areas of 112.4% (12.4% dilation, p
= 0.001). Treatment with 0.1 flg/ml CB markedly inhibited restenosis and
treatment with 1.5 flg/ml CB actually resulted in increased in lumenal area.
In this model of vascular injury, treatment with CB resulted in increased
Conclusions: Prolonged low dose local infusion of AP at the injury site
reduced the neointima and improved the residual lumen in the treated ves-
sel. The beneficial effect of AP was not demonstrated with the higher dose,
shorter duration local infusion.
Prolonged Local Endovascular Drug Delivery for
more than 14 Days with a New Catheter
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Local infusion of angiopeptin lAP) into injured swine coronary arteries using
the porous balloon has been shown to reduce neointima. The purpose of this
study was to compare prolonged (20 min) infusion of low dose AP (20 "g!kg)
with a short (3 mini infusion of high dose AP (500 "g!kg) using the Dispatch ,.
device which allows atraumatic and extended drug/arterial wall contact. 21
swine underwent overstretch balloon injury to the coronary arteries. AP was
infused at either low or high dose immediately post-injury. Vessels were har-
vested at 14 days and the neointimal area (NEG). % neointima INEOIWall
Area), % internal elastic lamina fracture (IEL break/lEL length) and residual
lumen (lumen area~umen area + intimal area) were determined.
P. Gonschior, C. Pahl, B. Holling. Med. Dept. I, Klinikum Grof3hadern, University of
Munich, Germany
Tissue hyperplasia is a characteristic feature of restenotic tissue. Local appli-
cation of antiproliferative drugs e.g. Photofrin II® (PFII; OLT, Canada). a pho-
tosensitive drug, might enable selective impairment of proliferating tissue
by photodynamic therapy or other antiproliferative strategies. The efficacy
of this therapy depends mainly on the method of drug application. Local
drug delivery (LDD) consisting of six thin injection needles (31 G) that can
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Efficacy of Cytochalasin B in Inhibiting Coronary
Restenosis Caused by Chronic Remodeling After
Balloon Trauma in Swine
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